262 related articles for article (PubMed ID: 17690183)
21. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.
Lewis J; Dickson DW; Lin WL; Chisholm L; Corral A; Jones G; Yen SH; Sahara N; Skipper L; Yager D; Eckman C; Hardy J; Hutton M; McGowan E
Science; 2001 Aug; 293(5534):1487-91. PubMed ID: 11520987
[TBL] [Abstract][Full Text] [Related]
22. Pathological tau tangles localize to focal cortical dysplasia in older patients.
Sen A; Thom M; Martinian L; Harding B; Cross JH; Nikolic M; Sisodiya SM
Epilepsia; 2007 Aug; 48(8):1447-54. PubMed ID: 17441989
[TBL] [Abstract][Full Text] [Related]
23. In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model.
Marinković P; Blumenstock S; Goltstein PM; Korzhova V; Peters F; Knebl A; Herms J
Brain; 2019 Apr; 142(4):1051-1062. PubMed ID: 30847469
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
25. Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein.
Probst A; Götz J; Wiederhold KH; Tolnay M; Mistl C; Jaton AL; Hong M; Ishihara T; Lee VM; Trojanowski JQ; Jakes R; Crowther RA; Spillantini MG; Bürki K; Goedert M
Acta Neuropathol; 2000 May; 99(5):469-81. PubMed ID: 10805089
[TBL] [Abstract][Full Text] [Related]
26. Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
Halverson RA; Lewis J; Frausto S; Hutton M; Muma NA
J Neurosci; 2005 Feb; 25(5):1226-33. PubMed ID: 15689560
[TBL] [Abstract][Full Text] [Related]
27. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.
Terwel D; Lasrado R; Snauwaert J; Vandeweert E; Van Haesendonck C; Borghgraef P; Van Leuven F
J Biol Chem; 2005 Feb; 280(5):3963-73. PubMed ID: 15509565
[TBL] [Abstract][Full Text] [Related]
28. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
[TBL] [Abstract][Full Text] [Related]
29. Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation.
Ferrer I; Pastor P; Rey MJ; Muñoz E; Puig B; Pastor E; Oliva R; Tolosa E
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):23-34. PubMed ID: 12581337
[TBL] [Abstract][Full Text] [Related]
30. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.
Terwel D; Dewachter I; Van Leuven F
Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809
[TBL] [Abstract][Full Text] [Related]
31. Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model.
Fox LM; William CM; Adamowicz DH; Pitstick R; Carlson GA; Spires-Jones TL; Hyman BT
J Neuropathol Exp Neurol; 2011 Jul; 70(7):588-95. PubMed ID: 21666499
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).
Ramsden M; Kotilinek L; Forster C; Paulson J; McGowan E; SantaCruz K; Guimaraes A; Yue M; Lewis J; Carlson G; Hutton M; Ashe KH
J Neurosci; 2005 Nov; 25(46):10637-47. PubMed ID: 16291936
[TBL] [Abstract][Full Text] [Related]
33. A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.
Rockenstein E; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Bisquert A; Trejo-Morales M; Spencer B; Masliah E
PLoS One; 2015; 10(3):e0121570. PubMed ID: 25803611
[TBL] [Abstract][Full Text] [Related]
34. Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits.
Gómez de Barreda E; Pérez M; Gómez Ramos P; de Cristobal J; Martín-Maestro P; Morán A; Dawson HN; Vitek MP; Lucas JJ; Hernández F; Avila J
Neurobiol Dis; 2010 Mar; 37(3):622-9. PubMed ID: 20004245
[TBL] [Abstract][Full Text] [Related]
35. Active c-jun N-terminal kinase induces caspase cleavage of tau and additional phosphorylation by GSK-3beta is required for tau aggregation.
Sahara N; Murayama M; Lee B; Park JM; Lagalwar S; Binder LI; Takashima A
Eur J Neurosci; 2008 Jun; 27(11):2897-906. PubMed ID: 18540881
[TBL] [Abstract][Full Text] [Related]
36. Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments.
Ishihara T; Higuchi M; Zhang B; Yoshiyama Y; Hong M; Trojanowski JQ; Lee VM
J Neurosci; 2001 Aug; 21(16):6026-35. PubMed ID: 11487626
[TBL] [Abstract][Full Text] [Related]
37. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.
Köhler C; Fuhr V; Dinekov M
Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467
[TBL] [Abstract][Full Text] [Related]
38. Familial parkinsonism and dementia with ballooned neurons, argyrophilic neuronal inclusions, atypical neurofibrillary tangles, tau-negative astrocytic fibrillary tangles, and Lewy bodies.
Mizutani T; Inose T; Nakajima S; Kakimi S; Uchigata M; Ikeda K; Gambetti P; Takasu T
Acta Neuropathol; 1998 Jan; 95(1):15-27. PubMed ID: 9452818
[TBL] [Abstract][Full Text] [Related]
39. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms.
Andorfer C; Kress Y; Espinoza M; de Silva R; Tucker KL; Barde YA; Duff K; Davies P
J Neurochem; 2003 Aug; 86(3):582-90. PubMed ID: 12859672
[TBL] [Abstract][Full Text] [Related]
40. Hyperphosphorylated tau aggregates in the cortex and hippocampus of transgenic mice with mutant human FTDP-17 Tau and lacking the PARK2 gene.
Guerrero R; Navarro P; Gallego E; Garcia-Cabrero AM; Avila J; Sanchez MP
Acta Neuropathol; 2009 Feb; 117(2):159-68. PubMed ID: 19057915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
